These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2591627)

  • 21. Endocrine ophthalmopathy: current ideas concerning etiology, pathogenesis, and treatment.
    Jacobson DH; Gorman CA
    Endocr Rev; 1984; 5(2):200-20. PubMed ID: 6376078
    [No Abstract]   [Full Text] [Related]  

  • 22. Role of octreoscan and correlation with MR imaging in Graves' ophthalmopathy.
    Kahaly G; Diaz M; Just M; Beyer J; Lieb W
    Thyroid; 1995 Apr; 5(2):107-11. PubMed ID: 7647569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Big muscles and big nerves.
    Dabbs CB; Kline LB
    Surv Ophthalmol; 1997; 42(3):247-54. PubMed ID: 9406370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.
    Feldon SE; Lee CP; Muramatsu SK; Weiner JM
    Arch Ophthalmol; 1985 Feb; 103(2):213-5. PubMed ID: 3838463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Graves'ophthalmopathy: usefulness of T2 weighted muscle signal intensity].
    Sillaire I; Ravel A; Dalens H; Garcier JM; Boyer L
    J Radiol; 2003 Feb; 84(2 Pt 1):139-42. PubMed ID: 12717285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The oculomotor muscles in Graves-Basedow disease in ultrasonic examination and computerized tomography].
    Janukowiczowa H; Iwaszkiewicz-Bilikiewiczowa B; Gardzilewiczowa A; Pacho R; Komarnicka R
    Klin Oczna; 1983 Oct; 85(10):343-5. PubMed ID: 6689349
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L; Norberg R
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of orbital muscle changes evaluated by magnetic resonance imaging and thyroid-stimulating antibody in patients with Graves' ophthalmopathy.
    Nishikawa M; Yoshimura M; Toyoda N; Masaki H; Yonemoto T; Gondou A; Kato T; Kurokawa H; Furumura T; Inada M
    Acta Endocrinol (Copenh); 1993 Sep; 129(3):213-9. PubMed ID: 8105634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Graves ophthalmopathy: MR imaging of the orbits.
    Hosten N; Sander B; Cordes M; Schubert CJ; Schörner W; Felix R
    Radiology; 1989 Sep; 172(3):759-62. PubMed ID: 2772184
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Dysthyroid ophthalmopathy].
    Shibuya S; Furusawa Y; Sato S; Shiga H; Kuroda H; Fujiwara K; Itoyama Y
    No To Shinkei; 1999 Oct; 51(10):912-3. PubMed ID: 10553596
    [No Abstract]   [Full Text] [Related]  

  • 31. Endocrine (immunogenic) orbitopathy--diagnostic and therapeutic experiences.
    Deckart H; Deckart E; Gerlach S; Winkelmann H; Wittwer M; Blottner A
    Dev Ophthalmol; 1989; 20():100-8. PubMed ID: 2687046
    [No Abstract]   [Full Text] [Related]  

  • 32. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
    Utech CI; Khatibnia U; Winter PF; Wulle KG
    Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiologically manifested accessory extraocular muscles in thyroid eye disease.
    Sinclair NE; Roberts MA; Hourihan MD; Walters RF; Lane CM
    Ophthalmic Plast Reconstr Surg; 2010; 26(4):286-8. PubMed ID: 20502362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A clinical analysis of Graves' ophthalmopathy and ophthalmic Graves' disease].
    Liao ZQ
    Zhonghua Yan Ke Za Zhi; 1992 Jul; 28(4):236-9. PubMed ID: 1299571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
    Pauleit D; Schüller H; Textor J; Leutner C; Keller E; Sommer T; Träber F; Block W; Boldt I; Schild H
    Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].
    Hosten N; Cordes M; Sander B; Schörner W; Wenzel KW; Felix R
    Rofo; 1990 Apr; 152(4):388-92. PubMed ID: 2160096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inferior oblique muscle biopsy in Graves' ophthalmopathy.
    Hoogenraad TU; Tan KE
    J R Soc Med; 1989 Sep; 82(9):571. PubMed ID: 2795584
    [No Abstract]   [Full Text] [Related]  

  • 38. [Possibilities for the demonstration and differentiation of eye muscle changes in endocrine orbitopathy and ocular myositis using nuclear magnetic resonance tomography].
    Wiegand W
    Klin Monbl Augenheilkd; 1986 Sep; 189(3):214-9. PubMed ID: 3784410
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent developments in Graves' ophthalmopathy imaging.
    Kahaly GJ
    J Endocrinol Invest; 2004 Mar; 27(3):254-8. PubMed ID: 15165001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Motility disturbances in Graves' ophthalmopathy.
    de Waard R; Koornneef L; Verbeeten B
    Doc Ophthalmol; 1983 Dec; 56(1-2):41-7. PubMed ID: 6689301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.